Red Queen Bio
7 known investors
Red Queen Bio builds an AI-powered biodefense system that rapidly designs and manufactures countermeasures against emerging biological threats, enabling faster defensive responses to evolving pathogenic risks.
Founders & leadership
HR

Hannu RajaniemiExecutive Director
NE

Nikolai EroshenkoCEO
Investors · 7
CompoundNew York · $400K – $1.5M
LongeVCWashington D.C.
The Venture CollectiveMiami Beach · $100K – $500K
Cerberus VenturesreportedNew York
Fifty YearsreportedSan Francisco · $250K – $2M
Also in the syndicate · 2
Halcyon FuturesOpenAIlead
Funding
SEC filings, press & company announcements$15M disclosed across 1 of 2 rounds · 2025
- Undisclosed amountseed financing roundDec 2025
OpenAI (lead)
Source ↗ - $15Mseed roundNov 2025 · 3 sources
OpenAI (lead), Cerberus Ventures, Fifty Years, Halcyon Futures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 1
by search overlapCompanies competing with Red Queen Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Red Queen Bio do?
- Red Queen Bio builds an AI-powered biodefense system that rapidly designs and manufactures countermeasures against emerging biological threats, enabling faster defensive responses to evolving pathogenic risks.
- Who founded Red Queen Bio?
- Red Queen Bio was founded by Hannu Rajaniemi, Nikolai Eroshenko.
- Who are Red Queen Bio's investors?
- Red Queen Bio's investors include Compound, LongeVC, The Venture Collective, Cerberus Ventures, Fifty Years.
- How much funding has Red Queen Bio raised?
- Red Queen Bio has disclosed $15M raised across 1 of its 2 known rounds.


